Barton Health first to implement Proteus’ digital health solution

Proteus Discover

Proteus Digital Health has scored the first client to implement its digital medicine product – Proteus Discover. Barton Health will deploy Proteus’ “Medicines as a Service” offering to improve health outcomes for patients with long-term chronic conditions who are having challenges managing their medications. The first implementation is focused on uncontrolled and co-morbid hypertension.

“This new product offering provides a data-driven communication channel between the medical provider and the patient that empowers the patient to take the appropriate dose of medication and better understand the importance of daily activity levels and other lifestyle changes,” Dr. Purvance, CEO of Barton Health, said in a statement.

Proteus Discover, which utilizes FDA-cleared technology from Proteus including ingestible sensors, has been clinically validated in this critical cardiovascular patient population. On activation, said sensor communicates with a small sensor patch worn by the patient that records the time of ingestion and personalized data such as heart rate, activity, and rest. This information is then relayed to the patient through a mobile app that also provides support and insight to the patient and allows them to share their data with their healthcare professional. Physicians and their care teams can access a web-based dashboard where they are provided with objective data that can inform personalized treatment decisions.

According to CrunchBase, Proteus Digital Health has raised $283.75 million to date.